Evaluating a nerve block treatment for shoulder stiffness
Evaluation of the Efficacy of Suprascapular Nerve Block in Adhesive Capsulitis: a Randomized Controlled Superiority Trial
This study is testing if a nerve block treatment can help people with shoulder stiffness feel better and move their shoulder more easily compared to regular treatments.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 62 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | CHU de Reims Academic / other |
| Locations | 1 site (Reims) |
| Trial ID | NCT06176248 on ClinicalTrials.gov |
What this trial studies
This interventional study aims to assess the effectiveness of suprascapular nerve block combined with conventional therapies for patients suffering from adhesive capsulitis, a condition that leads to reduced shoulder mobility. The study is designed as a double-blind trial to ensure unbiased results, comparing the outcomes of this nerve block technique against standard treatment methods. Participants will receive either the nerve block or a placebo, and their shoulder mobility and pain levels will be monitored over time to determine the efficacy of the intervention.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old diagnosed with adhesive capsulitis and experiencing significant loss of shoulder mobility.
Not a fit: Patients with recent shoulder surgery, certain medical conditions, or allergies to the treatment components may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly improve shoulder mobility and reduce pain for patients with adhesive capsulitis.
How similar studies have performed: While nerve block techniques have been used in various contexts, this specific combination with arthrodistension for adhesive capsulitis is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient treated for adhesive capsulitis corresponding to a loss of passive amplitude of more than 20° in external rotation elbow to body and/or abduction in relation to the contralateral shoulder. * Patient over 18 years of age * Patient covered by a social security scheme * Presence of an accompanying person on the day of the procedure for the return trip * Patient having signed the consent form to participate in the study Exclusion Criteria: * Patient protected by law * Pregnant women * Patient who has had shoulder surgery less than six months old * Patient unable to undergo rehabilitation within one month of surgery * Allergy to one of the products used (anesthetic, iodinated contrast medium) * Neuro-orthopedic disorder hampering clinical recovery * Hemostasis disorder contraindicating block (no discontinuation of anticoagulants according to SFAR recommendations, congenital hemostasis disorder)
Where this trial is running
Reims
- Chu Reims — Reims, France (Recruiting)
Study contacts
- Study coordinator: Lois BOLKO
- Email: lbolko@chu-reims.fr
- Phone: 03 26 78 80 80
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.